Corrects Q4 operating income to $46.8 mln from $17.7 mln in Key Details table

Overview

• Specialty chemicals firm's Q4 revenue fell 2%, missing analyst expectations

• Adjusted EPS for Q4 beat analyst expectations

• Company generated $61.4 mln in operating cash flow, improving net cash to $292.5 mln

Outlook

• Innospec expects margin and operating income improvement in Performance Chemicals and Oilfield Services in 2026

• Company anticipates consistent results from Fuel Specialties in 2026

Result Drivers

• FUEL SPECIALTIES - Operating income grew 7% driven by sales growth and margin improvement

• PERFORMANCE CHEMICALS - Sequential operating income growth due to margin improvement actions and lower personnel costs

• OILFIELD SERVICES - Improved operating income and margins from richer sales mix and lower overheads despite sales decline

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the specialty chemicals peer group is "buy"

• Wall Street's median 12-month price target for Innospec Inc is $100.00, about 15.5% above its February 13 closing price of $86.58

• The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release: ID:nGNX906SpV

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)